The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
312.00
+0.70 (0.22%)
At close: Apr 28, 2026
The IBN SINA Pharmaceutical Industry Employees
The IBN SINA Pharmaceutical Industry had 5,200 employees as of June 30, 2025. The number of employees increased by 1,000 or 23.81% compared to the previous year.
Employees
5,200
Change (1Y)
1,000
Growth (1Y)
23.81%
Revenue / Employee
2.59M BDT
Profits / Employee
151.60K BDT
Market Cap
9.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5,200 | 1,000 | 23.81% |
| Jun 30, 2024 | 4,200 | 200 | 5.00% |
| Jun 30, 2023 | 4,000 | 0 | - |
| Jun 30, 2022 | 4,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Asiatic Laboratories | 737 |
| Navana Pharmaceuticals | 4,798 |
| Orion Pharma | 2,954 |
| The ACME Laboratories | 9,025 |
| Techno Drugs | 1,438 |
| Beacon Pharmaceuticals | 4,771 |
| Unilever Consumer Care | 61 |
| Renata | 8,366 |